Featured series 
Tag: Aaron Kesselheim
-
Health
Why are ineffective oral decongestants still on store shelves?
Drug regulation expert explains how the problem was discovered, next steps for FDA, and the questions it raises about other products, supplements.
-
Health
Those breezy TV drug ads? Take ’em with a grain of salt
A new study shows that advertising may not work so well at promoting treatments that are significantly better than other options.
-
Work & Economy
COVID vaccine race leaders likely won’t be only ones to reap huge payday
The coronavirus pandemic will likely make some vaccine companies rich, but which companies and how rich relies on the still-murky future of the pandemic, a Harvard health policy expert said.
-
Health
The changes in drug research, testing
In December, Congress passed a bipartisan law to boost federal medical research spending and to ease the approval of new drugs. In a panel discussion, experts at the Harvard T.H. Chan School of Public Health talked about its pros and cons, including whether it will be funded, and whether the relaxed drug approval guidelines are…
-
Health
Drug story
Americans often have no idea whether they’re getting value for their prescription drug dollars, something that has to change if costs are to be reigned in in this country, according to a panel at the Harvard T.H. Chan School of Public Health.
-
Health
The threat from superbugs
Hospital stewardship programs, community education, and legal changes to allow pharmaceutical companies to profit longer from new antibiotics are among reforms that experts suggest to fight drug-resistant bacteria.
